Opioid-Induced Constipation (OIC) Market Key Players – Ironwood Pharmaceuticals Inc, Shionogi & Co Ltd, and Theravance Biopharma Inc Analysis & Forecast 2018 to 2022

Opioid-Induced Constipation (OIC)

Overview

Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect the gastrointestinal tract in a variety of ways. Opioids increase the amount of time it takes stool to move through the gastric system. They increase non-propulsive contractions in the middle of the small intestine (jejunum) and decrease longitudinal propulsive peristalsis - motions critical to moving food through the intestines.

This results in food that fails to travel through the digestive tract. Opioids are also able to partially paralyze the stomach (gastroparesis) so that food remains in the digestive organ for a longer period of time. Additionally opioids reduce digestive secretions and decrease the urge to defecate. Symptoms of OIC include feeling and being sick, tiredness and lethargy, appetite loss, feeling depressed.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2966993-opioid-induced-constipation-oic-pipeline-review-h1-2018

Top Companies mentioned

Ironwood Pharmaceuticals Inc

Shionogi & Co Ltd

Sucampo Pharmaceuticals Inc

Synergy Pharmaceuticals Inc

Theravance Biopharma Inc

Opioid-Induced Constipation (OIC) Global Industry Major Highlights:

The pipeline guide provides a snapshot of the global therapeutic landscape of Opioid-Induced Constipation (OIC) (Toxicology). 
The pipeline guide reviews pipeline therapeutics for Opioid-Induced Constipation (OIC) (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
The pipeline guide reviews key companies involved in Opioid-Induced Constipation (OIC) (Toxicology) therapeutics and enlists all their major and minor projects. 
The pipeline guide evaluates Opioid-Induced Constipation (OIC) (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. 
The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. 

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. 

Find and recognize significant and varied types of therapeutics under development for Opioid-Induced Constipation (OIC) (Toxicology).

Classify potential new clients or partners in the target demographic. 

Opioid-Induced Constipation (OIC) - Competitive Analysis

Key players are making innovative developments in Opioid-Induced Constipation (OIC) industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2966993-opioid-induced-constipation-oic-pipeline-review-h1-2018

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.